For sale by healthy soul enterprise VERIFIED 4 Dec 5:08 pmKoforidua, Eastern
There is strong evidence that omega-3 fatty acids have a beneficial effect in bipolar disorder.
Omega-3 fatty acid supplementation is associated with reduced mania and depression in juvenile bipolar disorder.
Clinical studies have reported that oral fish oil supplementation has beneficial effects in rheumatoid arthritis and among some asthmatics.
Fish oil improves tubular dysfunction, lipid profiles and oxidative stress in patients with IgA nephropathy.
Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.
Omega 3 fatty acids improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.
Omega-3 in modest doses reduces cardiac deaths, and in high doses reduces nonfatal cardiovascular events.
Dietary supplementation with omega-3 fatty acids reduces the incidence of sudden cardiac death in patients with myocardial infarction.
Omega-3 fatty acid reduce the total mortality and sudden death in patients with left ventricular systolic dysfunction.
Raising blood levels of omega-3 fatty acid levels may be 8 times effective than distributing automated external defibrillators (AEDs), and 2 times more effective than implanting implanting cardioverter defibrillators (ICDs) in preventing sudden death.
Omega-3 fatty acid supplementation reduces total mortality and sudden death in patients who have already had a heart attack.
Consuming small quantities of fish is associated with a reduction in coronary heart disease.
Omega-3 fatty acids and vitamin D supplementation results in a substantial reduction in coronary calcium scores and slowed plaque growth.
Omega-3 fatty acids prevent atrial fibrillation after coronary artery bypass surgery.
Omega-3 fatty acid supplementation has a therapeutic effect in children with ADHD.
A combination of omega-3 and omega-6 fatty acids as well as magnesium and zinc consumption provide a beneficial effect on attentional, behavioural, and emotional problems of children and adolescents.
Fish oil supplementation has a significant therapeutic effect on children with autism.
Omega-3 fatty acids appear to be an effective treatment for children with autism.
The consumption of omega-3 fatty acid supplements decreases homocysteine levels in diabetic patients.
Omega-3 fatty acids improve macro- and microvascular function in subjects with type 2 diabetes mellitus.
In patients with stable coronary artery disease, an independent and inverse association exists between n-3 fatty acid levels and inflammatory biomarkers.
Omega-3 fatty acids improve endothelial function in peripheral arterial disease.
Fish oil has a beneficial effect on blood viscosity in peripheral vascular disease.
Fish oil supplementation improves walking distance in peripheral arterial disease.
The omega-3 fatty acid docosapentaenoic acid (DPA) reduces the risk of peripheral arterial diseaseassociated with smoking.
An 8-month treatment with omega-3 fatty acids (EPA and DHA) has a positive effects, such as decreasing inflammation, in patients with cystic fibrosis.
Omega-3 fatty acids may have a protective effect against mucus over-production caused by pulmonary bacterial colonization in cystic fibrosis.
Omega-3 fatty acid supplementation reduces inflammatory biomarkers, erythrocyte sedimentation rate, and interleukin-8 concentrations in cystic fibrosis patients.
DHA increases resistance to Pseudomonas aeruginosa infection.
EPA supplementation has therapeutic value in the treatment of chronic hepatitis C patients.
EPA and DHA have therapeutic value in the treatment of systemic lupus erythmeatosus.
Omega-3 fish oil reduces the severity of symptoms in patients with systemic lupus
Watch out for: